Abstract

Treatment of severe symptomatic aortic stenosis has undergone significant changes with the advent of transcatheter aortic valve replacement (TAVR). Initially reserved for inoperable patients, these devices have improved; outcomes now rival or outperform surgical treatment. TAVR is recommended for high-risk and certain intermediate-risk patients. As transcatheter aortic valve replacement becomes an option for younger, healthier patients, long-term planning and thoughtful considerations of potential subsequent interventions are paramount. A robust understanding of risks, benefits and expected outcomes with TAVR is critical to provide patients with the best treatment option.

Original languageEnglish (US)
Pages (from-to)425-433
Number of pages9
JournalInterventional Cardiology Clinics
Volume7
Issue number4
DOIs
StatePublished - Oct 1 2018

Keywords

  • Aortic stenosis
  • Appropriate use
  • Indication
  • Surgery
  • Transcatheter therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'When to Choose Surgery in the Era of Transcatheter Aortic Valve Replacement'. Together they form a unique fingerprint.

Cite this